Li Q, Cao M, Lei L, Yang F, Li H, Yan X, He S, Zhang S, Teng Y, Xia C, Chen W. Burden of liver cancer: From epidemiology to prevention. Chin J Cancer Res. 2022;34(6):554–66. https://doi.org/10.21147/j.issn.1000-9604.2022.06.02.

Article  PubMed  PubMed Central  Google Scholar 

Tunissiolli N, Castanhole-Nunes M, Biselli-Chicote P, Pavarino É, Silva R, Silva R, Goloni-Bertollo E. Hepatocellular carcinoma: a comprehensive review of biomarkers, clinical aspects, and therapy. Asian Pac J Cancer Prev. 2017;18:863–72.

PubMed  PubMed Central  Google Scholar 

Golabi P, Fazel S, Otgonsuren M, Sayiner M, Locklear C, Younossi Z. Mortality assessment of patients with hepatocellular carcinoma according to underlying disease and treatment modalities. Medicine (Baltimore). 2017. https://doi.org/10.1097/MD.0000000000005904.

Article  PubMed  Google Scholar 

Tang W, Chen Z, Zhang W, Cheng Y, Zhang B, Wu F, Wang Q, Wang S, Rong D, Reiter F, Toni E, Wang X. The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects. Signal Transduct Target Ther. 2020;5:87. https://doi.org/10.1038/s41392-020-0187-x.

Article  PubMed  PubMed Central  Google Scholar 

Yang G, Xing J, Aikemu B, Jing S, Minhua Z. Kaempferol exhibits a synergistic effect with doxorubicin to inhibit proliferation, migration, and invasion of liver cancer. Oncol Rep. 2021;45:32. https://doi.org/10.3892/or.2021.7983.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang Y, Zhang Y, Shi X, Li J, Wang L, Xie C, Wang Y. Chenodeoxycholic acid enhances the effect of sorafenib in inhibiting HepG2 cell growth through EGFR/Stat3 pathway. Front Oncol. 2022. https://doi.org/10.3389/fonc.2022.836333.

Article  PubMed  PubMed Central  Google Scholar 

Erstad D, Tanabe K. Hepatocellular carcinoma: early-stage management challenges. J Hepatocell Carcinoma. 2017;4:81–92. https://doi.org/10.2147/JHC.S107370.

Article  PubMed  PubMed Central  Google Scholar 

Yang J, Hainaut P, Gores G, Amadou A, Plymoth A, Roberts L. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 2019;16:589–604. https://doi.org/10.1038/s41575-019-0186-y.

Article  PubMed  PubMed Central  Google Scholar 

Silva M, Sherman M. Criteria for liver transplantation for HCC: what should the limits be? J Hepatol. 2011;55:1137–47. https://doi.org/10.1016/j.jhep.2011.05.012.

Article  PubMed  Google Scholar 

Chawla A, Ferrone C. Hepatocellular carcinoma surgical therapy perspectives on the current limits to resection. Chin Clin Oncol. 2018;7:48.

Article  PubMed  Google Scholar 

Zhang Z, Zhou L, Xie N, Edouard N, Zhang T, Cui Y, Huang C. Overcoming cancer therapeutic bottleneck by drug repurposing. Signal Transduct Target Ther. 2020;5:113. https://doi.org/10.1038/s41392-020-00213-8.

Article  PubMed  PubMed Central  Google Scholar 

Lin S, Chueh S, Hsiao C, Li T, Chen T, Liao C, Lyu P, Guh J. Prazosin displays anticancer activity against human prostate cancers: targeting DNA and cell cycle. Neoplasia. 2007;9:830–9. https://doi.org/10.1593/neo.07475.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kamgar-Dayhoff P, Brelidze T. Multifaceted effect of chlorpromazine in cancer implications for cancer treatment. Oncotarget. 2021;12:1406.

Article  PubMed  PubMed Central  Google Scholar 

Papadopoulos F, Isihou R, Alexiou G, Tsalios T, Vartholomatos E, Markopoulos G, Sioka C, Tsekeris P, Kyritsis A, Galani V. Haloperidol induced cell cycle arrest and apoptosis in glioblastoma cells. Biomedicines. 2020;8:595. https://doi.org/10.3390/biomedicines8120595.

Article  CAS  PubMed  PubMed Central  Google Scholar 

An M, Ma W, Jia H, Li Y, Feng J, Meng J, Hui Q, Liu J. Prazosin inhibits the growth and mobility of osteosarcoma cells. Transl Cancer Res. 2019;8:1997.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu F, Xi H, Liao M, Zhang Y, Ma H, Wu M, Xue Q, Sun H, Zhang Y, Xia Y. Repurposed antipsychotic chlorpromazine inhibits colorectal cancer and pulmonary metastasis by inducing G2/M cell cycle arrest, apoptosis, and autophagy. Cancer Chemother Pharmacol. 2022;89:331–46. https://doi.org/10.1007/s00280-021-04386-z.

Article  CAS  PubMed  Google Scholar 

Tang D, Kang R, Berghe TV, Vandenabeele P, Kroemer G. The molecular machinery of regulated cell death. Cell Res. 2019;29:347–64. https://doi.org/10.1038/s41422-019-0164-5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pan F, Lin X, Hao L, Wang T, Song H, Wang R. The critical role of ferroptosis in hepatocellular carcinoma. Front Cell Dev Biol. 2022. https://doi.org/10.3389/fcell.2022.882571.

Article  PubMed  PubMed Central  Google Scholar 

Poon I, Hulett M, Parish C. Molecular mechanisms of late apoptotic/necrotic cell clearance. Cell Death Differ. 2010;17:381–97. https://doi.org/10.1038/cdd.2009.195.

Article  CAS  PubMed  Google Scholar 

Shlomovitz I, Speir M, Gerlic M. Flipping the dogma – phosphatidylserine in non-apoptotic cell death. Cell Commun Signal. 2019;17:139. https://doi.org/10.1186/s12964-019-0437-0.

Article  PubMed  PubMed Central  Google Scholar 

Morgan K, Martucci N, Kozlowska A, et al. Chlorpromazine toxicity is associated with disruption of cell membrane integrity and initiation of a pro-inflammatory response in the HepaRG hepatic cell line. Biomed Pharmacother. 2019;111:1408–16. https://doi.org/10.1016/j.biopha.2019.01.020.

Article  CAS  PubMed  Google Scholar 

Fuchs R, Schwach G, Stracke A, et al. The anti-hypertensive drug prazosin induces apoptosis in the medullary thyroid carcinoma cell line TT. Anticancer Res. 2015;35(1):31–8.

CAS  PubMed  PubMed Central  Google Scholar 

Lin SC, Chueh SC, Hsiao CJ, et al. Prazosin displays anticancer activity against human prostate cancers: targeting DNA and cell cycle. Neoplasia. 2007;9(10):830–9. https://doi.org/10.1593/neo.07475.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rai S, Tanaka H, Suzuki M, et al. Chlorpromazine eliminates acute myeloid leukemia cells by perturbing subcellular localization of FLT3-ITD and KIT-D816V. Nat Commun. 2020;11(1):4147. https://doi.org/10.1038/s41467-020-17666-8.

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Mann, S.K., Marwaha, R., Chlorpromazine. In: StatPearls. StatPearls Publishing; 2024. http://www.ncbi.nlm.nih.gov/books/NBK553079/

Basquez, R., Pippin, M.M. Prazosin. In: StatPearls. StatPearls Publishing; 2024. http://www.ncbi.nlm.nih.gov/books/NBK555959/

Fang J, Han T, Wu Q, Beland F, Chang C, Guo L, Fuscoe J. Differential gene expression in human hepatocyte cell lines exposed to the antiretroviral agent zidovudine. Arch Toxicol. 2014;88:609–23. https://doi.org/10.1007/s00204-013-1169-3.

Article  CAS  PubMed  Google Scholar 

Li Y, Zuo H, Wang H, Hu A. Decrease of MLK4 prevents hepatocellular carcinoma (HCC) through reducing metastasis and inducing apoptosis regulated by ROS/MAPKs signaling. Biomed Pharmacother. 2019. https://doi.org/10.1016/j.biopha.2019.108749.

Article  PubMed  Google Scholar 

Srinivas U, Tan B, Vellayappan B, Jeyasekharan A. ROS and the DNA damage response in cancer. Redox Biol. 2019. https://doi.org/10.1016/j.redox.2018.101084.

Article  PubMed  Google Scholar 

Zhang, Y., Cao, Y., Luo, S., Mukerabigwi, J.F., Liu, M. Chapter 8 - Nanoparticles as drug delivery systems of combination therapy for cancer. In: Grumezescu AM, ed. Nanobiomaterials in Cancer Therapy. William Andrew Publishing, 2016, 253–280. doi:https://doi.org/10.1016/B978-0-323-42863-7.00008-6

Yu B, Tai HC, Xue W, Lee LJ, Lee RJ. Receptor-targeted nanocarriers for therapeutic delivery to cancer. Mol Membr Biol. 2010;27(7):286–98. https://doi.org/10.3109/09687688.2010.521200.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lancet JE, Uy GL, Cortes JE, et al. CPX-351 (cytarabine and daunorubicin) liposome for injection versus conventional cytarabine plus daunorubicin in older patients with newly diagnosed secondary acute myeloid leukemia. J Clin Oncol. 2018;36(26):2684–92. https://doi.org/10.1200/JCO.2017.77.6112.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Juaid N, Amin A, Abdalla A, et al. Anti-hepatocellular carcinoma biomolecules: molecular targets insights. Int J Mol Sci. 2021;22(19):10774. https://doi.org/10.3390/ijms221910774.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Singh A, Mishra S, Sharma S, Ojha S, Yagnik S, Pandey S. Ligand-mediated targeted drug delivery approaches against hepatocellular carcinoma. Curr Cancer Drug Targets. 2023;23(11):879–88. https://doi.org/10.2174/1568009623666230503094346.

Article  CAS  PubMed  Google Scholar